BioMarin to acquire Amicus Therapeutics in $4.8 billion deal

MELBOURNE - BioMarin Pharmaceutical Inc has agreed to acquire Amicus Therapeutics Inc in an all-cash deal valued at approximately $4.8 billion, the companies said on Monday. The acquisition includes Amicus's…

NNR December 22, 2025

Euronext

Fagron NV has acquired Amber Compounding Pharmacy, Brazil’s Vepakum

AMSTERDAM - Belgian pharmaceutical compounding giant Fagron NV announced on Friday two strategic acquisitions to expand its presence in Asia-Pacific and Brazil, coupled with a crucial regulatory license in the United…

NNR December 19, 2025

Wire

Royalty Pharma acquires Nuvalent cancer drug royalties in $315 million deal

NEW YORK - Royalty Pharma plc said on Tuesday it acquired a royalty interest in two of Nuvalent Inc's experimental lung cancer therapies for up to $315 million, betting on…

NNR December 16, 2025

London Stock Exchange

AstraZeneca to invest $2 billion in Maryland manufacturing expansion, creating 2,600 jobs

GAITHERSBURG – AstraZeneca said on Monday it will invest $2 billion to expand its manufacturing footprint in Maryland, including a major expansion of its biologics facility in Frederick and construction…

Ali Mirza November 24, 2025

Euronext

Hyloris Pharmaceuticals SA partners with China’s Grand Life Sciences

LIEGE: Belgian biopharmaceutical company Hyloris Pharmaceuticals SA said on Monday it has signed an exclusive license and distribution agreement with China's Grand Life Sciences Group Co., Ltd. for HY-094, its…

NNR October 27, 2025

Wire

Novartis to buy Avidity Biosciences in $12 billion RNA therapeutics bet

ZURICH: Swiss drugmaker Novartis (NOVN.S) said on Sunday it has agreed to acquire U.S. biotech firm Avidity Biosciences (RNA.O) in a deal valued at approximately $12 billion, expanding its reach…

NNR October 26, 2025

Companies listed on London Stock Exchange

Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC is an England-based business involved in the development and marketing of veterinary products. It is listed on the London Stock Exchange and is a constituent of the…

NNR August 13, 2020